Skip to content

Natera, Inc. NTRA Total Cost of Revenue

Total Cost of Revenue at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$62.8M+1.8%
Labcorp Holdings logo
Labcorp HoldingsLH
$2.52B+5.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1.95B+9.2%
NeoGenomics logo
NeoGenomicsNEO
$105.81M+11.6%
Illumina logo
IlluminaILMN
$370M+3.4%
CareDx logo
CareDxCDNA
$15.03M+30.5%

Other financials

Income statement

See full
Revenue$696.6M+38.8%
Operating income-$93.5M-18.1%
Net income-$85.1M-27.1%
EPS (diluted)-$0.60-20.0%

Balance sheet

See full
Cash & equivalents$1.1B+11.7%
Total debt$240.1M+22.7%
Total equity$1.8B+43.1%
Total assets$2.6B+50.9%

Cash flow

See full
Operating cash flow$40.2M-9.6%
CapEx$22.1M+1.5%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$37.51B+73.4%
Enterprise value$36.66B+76.0%
P/S15×+4.0×

Profitability

See full
Gross margin42.9%
Operating margin-13%+0.6pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.9×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Natera, Inc.’s 10-Q, filed August 7, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.